EARN
Phase NA Completed
33 enrolled
DELFI-L101
Completed
2,992 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
ROOT
Completed
167 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
Phase 1/2 Completed
113 enrolled 22 charts
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Phase 1 Completed
34 enrolled
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Phase 1/2 Completed
62 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
Health Communication in Families
Completed
42 enrolled
PAMCap
Completed
32 enrolled
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Phase 1 Completed
58 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Phase 2 Completed
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients
Phase NA Completed
568 enrolled
Study of NS-9 in Patients With Liver Metastases
Phase 1 Completed
20 enrolled